What is the appropriate management for a dog that ingested one bromadiolone-containing rodenticide cake?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Bromadiolone Ingestion in Dogs

For a dog that ingested one bromadiolone cake, immediately induce emesis if the ingestion occurred within 1 hour, then initiate vitamin K1 therapy and monitor coagulation parameters.

Immediate Management Algorithm

Step 1: Induce Emesis (If Within 1 Hour)

  • Administer apomorphine to induce vomiting if ingestion occurred within the past hour 1
  • Evidence shows that emesis induced within 1 hour can recover 10-77% of ingested bromadiolone, as the toxin is not fully absorbed during this timeframe 1
  • This is the single most effective intervention to reduce toxin exposure before systemic absorption occurs

Step 2: Initiate Vitamin K1 Therapy

Begin vitamin K1 treatment immediately, even before clinical signs develop:

  • Intravenous vitamin K1: 10 mg/kg initially for rapid correction of coagulopathy 2
  • Pretreat with 1 mg/kg prednisolone to prevent potential anaphylactic reactions 2
  • Transition to oral vitamin K1 for 30 days of continued therapy 3

Step 3: Baseline Coagulation Testing

Obtain prothrombin time (PT) and activated partial thromboplastin time (aPTT) immediately:

  • These will be your baseline for monitoring treatment response
  • PT is typically prolonged first and most consistently 4, 2
  • aPTT may also be prolonged in most cases 2

Clinical Monitoring

What to Watch For

Bromadiolone is a second-generation anticoagulant rodenticide (the most common type causing toxicity, accounting for 92% of cases) 4. Clinical signs, if they develop, typically include:

  • Lethargy (86% of symptomatic cases) 4
  • Dyspnea/tachypnea (55-60%) - often indicating pleural space hemorrhage, the most common bleeding site (43% of hemorrhages) 4, 2
  • Pale mucous membranes (79%) 2
  • External hemorrhage (44%) 4
  • Ocular manifestations (subconjunctival hemorrhage, exophthalmos, orbital pain) in rare cases 3

Critical Pitfall

Only 4% of owners actually witness the ingestion 2, so maintain high clinical suspicion in any dog presenting with non-specific signs like lethargy and anorexia, especially during July-October when 53% of cases occur 4.

If Hemorrhage Develops

Blood Product Administration

  • Fresh frozen plasma is the most commonly used product (56% of cases with hemorrhage) 4
  • Blood product administration significantly improves survival: 81% survival in dogs receiving transfusions versus 19% in those that did not (P = 0.017) 4
  • Administer blood products to any dog showing clinical evidence of hemorrhage

Thrombocytopenia Consideration

  • Consumptive thrombocytopenia occurs in 24% of dogs with AR-induced hemorrhage 4
  • Moderate thrombocytopenia (platelet count <60 K/μL) occurs in approximately 7/12 affected dogs 4
  • This does not change management but explains why some dogs bleed more severely

Prognosis and Follow-up

The prognosis is excellent with appropriate treatment: 86% of dogs with AR-induced hemorrhage survive to discharge, and 94% of all treated dogs are discharged after a median of 3 days hospitalization 4, 2.

  • Recheck PT/aPTT at 3 days to confirm normalization 1
  • Continue oral vitamin K1 for the full 30-day course to prevent relapse, as bromadiolone has a prolonged half-life
  • Most dogs achieve physiological or near-physiological coagulation parameters before discharge 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.